Japan's national health insurance (NHI) system will include infertility treatments in its reimbursement coverage from 1 April 2022, in a policy move set to transform access and which looks set to lead to substantial growth in the market in the country.
Japan’s New Infertility Coverage To Drive The Market
ART Drugs Approved At Fast Pace
Japan's national health insurance scheme will reimburse infertility treatments from April 2022, in a bid to make the treatments more accessible to patients by effectively lowering the cost by 70%. The key strategic aim is to raise a low birth rate and the move is also set to substantially expand the market for such products for both domestic and foreign players.
